IgE Depletion in Severe Asthma: What We Have and What Could Be Added in the Near Future

IgE Depletion in Severe Asthma: What We Have and What Could Be Added in the Near Future

Bibliographic Details
Main Authors:	Cristoforo Incorvaia, Gian Galeazzo Riario-Sforza, Erminia Ridolo
Format:	Article
Language:	English
Published:	Elsevier 2017-03-01
Series:	EBioMedicine
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352396417300828

Similar Items

Do not intubate order, is the misunderstanding finally over?
by: Cristoforo Incorvaia, et al.
Published: (2018-01-01)

Sublingual immunotherapy in allergic asthma: Current evidence and needs to meet
by: Incorvaia Cristoforo, et al.
Published: (2010-01-01)

Effects of pulmonary rehabilitation on exercise capacity in patients with COPD: A number needed to treat study
by: Gian Galeazzo Riario-Sforza, et al.
Published: (2009-08-01)

Impairment of small airways in COPD patients with frequent exacerbations and effects of treatment with tiotropium
by: Cristoforo Incorvaia, et al.
Published: (2008-03-01)

Preventive actions of allergen immunotherapy: the facts and the effects in search of evidence
by: Irene Martignago, et al.
Published: (2017-06-01)

Can the Pattern of Early Sensitization to Allergen Molecules Drive a New Approach for Prevention of Allergy?
by: Cristoforo Incorvaia, et al.
Published: (2017-12-01)

Skin reaction to inhaled tiotropium bromide: a case report
by: Megali Raffaella, et al.
Published: (2011-03-01)

Six-Minute Walk Test cut-off value identifying COPD patients with physical disability: a pilot study
by: Cristoforo Incorvaia, et al.
Published: (2016-01-01)

Two decades with omalizumab: what we still have to learn
by: Incorvaia C, et al.
Published: (2018-10-01)

Mabs for treating asthma: omalizumab, mepolizumab, reslizumab, benralizumab, dupilumab
by: Erminia Ridolo, et al.
Published: (2020-10-01)

Assessing the Risk Factors for Refractory Eosinophilic Esophagitis in Children and Adults
by: Erminia Ridolo, et al.
Published: (2019-01-01)

Striving for optimal bronchodilation: focus on olodaterol
by: Incorvaia C, et al.
Published: (2016-03-01)

Role of indacaterol and the newer very long-acting β2-agonists in patients with stable COPD: a review
by: Ridolo E, et al.
Published: (2013-09-01)

Ecosystems Disturbance Recovery: What It Was or What It Could Have Been?
by: Hamid Dashti, et al.
Published: (2024-09-01)

Relevance of serum specific IgE and total IgE estimation in asthma patients with pigeon exposure
by: Anil Kumar Mavi, et al.
Published: (2020-08-01)

Recurrent asthma exacerbations: What else could it be?
by: Hawa Edriss, et al.
Published: (2018-01-01)

Specific IgE response to different grass pollen allergen components in children undergoing sublingual immunotherapy
by: Marcucci Francesco, et al.
Published: (2012-06-01)

1944: What Was Known? What Was Reported? What Was Done? What Could Have Been Done?
by: Franklin Bialystok
Published: (2019-06-01)

Personalized medicine and allergen immunotherapy: the beginning of a new era?
by: Cristoforo Incorvaia, et al.
Published: (2021-07-01)

Local allergic rhinitis: evolution of concepts
by: Cristoforo Incorvaia, et al.
Published: (2017-11-01)

What is Language and How Could it Have Evolved?
by: Bolhuis, Johan J., et al.
Published: (2020)

Omalizumab, an anti-immunoglobulin E antibody: state of the art
by: Incorvaia C, et al.
Published: (2014-02-01)

Anti-IgE for asthma in inner-city children.
by: Pavord, I, et al.
Published: (2011)

Anti-IgE for asthma in inner-city children
by: Pavord, I, et al.
Published: (2011)

Omalizumab and IgE in the Control of Severe Allergic Asthma
by: Yasuhiro Gon, et al.
Published: (2022-03-01)

The rationale for treating allergic asthma with anti-IgE
by: E. Hamelmann
Published: (2007-09-01)

Levels of total IgE versus specific IgE during childhood for defining and predicting T2-high asthma
by: Tamo Sultan, MD, et al.
Published: (2024-12-01)

Tetrachlorophthalic anhydride asthma: evidence for specific IgE antibody.
by: Howe, W, et al.
Published: (1983)

Tetrachlorophthalic anhydride asthma: Evidence for specific IgE antibody
by: Venables, K, et al.
Published: (1982)

Tetrachlorophthalic anhydride asthma: evidence for specific IgE antibody
by: Howe, W, et al.
Published: (1983)

ANTI-IgE THERAPY — BREAKTHROUGH IN TREATMENT FOR BRONCHIAL ASTHMA
by: article editorial
Published: (2007-06-01)

ANTI-IgE THERAPY — BREAKTHROUGH IN TREATMENT FOR BRONCHIAL ASTHMA
by: article editorial
Published: (2007-06-01)

Leptin, Obesity and IgE in patients with Asthma and Allergic Rhinitis
by: Adnan Hasan Alwan, et al.
Published: (2019-11-01)

Leptin, Obesity and IgE in patients with Asthma and Allergic Rhinitis
by: Adnan Hasan Alwan, et al.
Published: (2019-11-01)

Extracorporeal IgE Immunoadsorption in Allergic Asthma: Safety and Efficacy
by: Christian Lupinek, et al.
Published: (2017-03-01)

Serum IgE reactivity profiling in an asthma affected cohort.
by: Tania Dottorini, et al.
Published: (2011-01-01)

Severe asthma: anti-IgE or anti-IL-5?
by: Evgenia Papathanassiou, et al.
Published: (2016-11-01)

Omalizumab in the management of patients with allergic (IgE-mediated) asthma
by: Thomas Sandstr&ouml;m
Published: (2009-05-01)

Anti-IgE Treatment for Disorders Other Than Asthma
by: Jeffrey Stokes
Published: (2017-09-01)

Effect of patient education on adherence to drug treatment for chronic obstructive pulmonary disease
by: C Incorvaia, et al.
Published: (2011-01-01)